Gemfibrozil and hepatitis Patient Reports February 10, 2012

Gemfibrozil Side Effects Report #5029226-3
Gemfibrozil side effect was reported by a Health Professional from CROATIA (local name: Hrvatska) on May 31, 2006. Female patient, 61 years of age, was diagnosed with malignant melanoma and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: condition aggravated, hepatitis , hyperlipidaemia. Gemfibrozil dosage: 600 MG (600 MG, 1 IN 1 D); ORAL. During the same period patient was treated with INTRON A. Patient recovered.

Gemfibrozil Side Effects Report #5036643-4
Gemfibrozil side effect was reported by a Physician from CROATIA (local name: Hrvatska) on June 15, 2006. Female patient, 61 years of age, was diagnosed with malignant melanoma and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: eosinophil count decreased, hepatitis . Gemfibrozil dosage: 600 MG (600 MG, 1 IN 1 D), ORAL. During the same period patient was treated with INTRON A. Patient recovered.

Gemfibrozil Side Effects Report #5081611-X
Gemfibrozil side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Aug 02, 2006. Female patient, 61 years of age, was diagnosed with hypertriglyceridaemia, malignant melanoma and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: hepatitis . Gemfibrozil dosage: 600 MG, DAILY, ORAL. During the same period patient was treated with INTRON A, INTRON A, INTRON A, INTRON A. Patient recovered.

Gemfibrozil Side Effects Report #5714124-X
Gemfibrozil side effect was reported by a Pharmacist from UNITED STATES on Apr 22, 2008. Male patient, 85 years of age, was diagnosed with hyperlipidaemia, cardiovascular event prophylaxis and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: fall , haemodialysis, hepatitis , renal failure acute, rhabdomyolysis. Gemfibrozil dosage: 600MG BID PO. During the same period patient was treated with SIMVASTATIN, RANITIDINE, GALANTAMINE, QUETIAPINE, SPIRIVA. Patient was hospitalized. Patient recovered.